Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 4/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | APEX1 | P27695 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 2/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.31 |
| ▸ | HPGD | P15428 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclohexane SCHEMBL27945853 | 0.92 | KDM4E (0.37) | L3MBTL1EPHX1MEN1KMT2APOLB | |
| SCHEMBL14680931 | 0.82 | EPHX1 (0.37) | L3MBTL1EPHX1MEN1KMT2APOLB | |
| SCHEMBL21306959 | 0.79 | ALDH1A1 (0.39) | L3MBTL1EPHX1MEN1KMT2APOLB | |
| SCHEMBL11739867 | 0.76 | ALDH1A1 (0.43) | L3MBTL1MEN1KMT2AALDH1A1TP53 | |
| SCHEMBL20953659 | 0.75 | MEN1 (0.40) | L3MBTL1EPHX1MEN1KMT2APOLB | |
| SCHEMBL153717 | 0.75 | L3MBTL1 (0.42) | L3MBTL1EPHX1MEN1KMT2APOLB | |
| SCHEMBL25564484 | 0.75 | MEN1 (0.40) | L3MBTL1EPHX1MEN1KMT2APOLB | |
| SCHEMBL13020558 | 0.74 | POLB (0.36) | EPHX1MEN1KMT2APOLBAPEX1 | |
| SCHEMBL18016462 | 0.73 | ALDH1A1 (0.42) | L3MBTL1EPHX1MEN1KMT2APOLB | |
| SCHEMBL10912920 | 0.72 | EPHX1 (0.31) | EPHX1POLBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 258 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014055603-A1 | PROCESS FOR THE PREPARATION OF AN HIV INTEGRASE INHIBITOR | GILEAD SCIENCES, INC. (US) | 2014-04-10 | — | — | WO | claimed |
| EP-2694479-A1 | PROCESS FOR THE PREPARATION OF AN HIV INTEGRASE INHIBITOR | Gilead Sciences, Inc. (US) | 2014-02-12 | — | — | EP | claimed |
| WO-2012138670-A1 | PROCESS FOR THE PREPARATION OF AN HIV INTEGRASE INHIBITOR | GILEAD SCIENCES, INC. (US) | 2012-10-11 | — | — | WO | claimed |
| CN-122070279-A | Fibroblast activation protein inhibitor | 苏州博锐创合医药有限公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-116003565-B | Preparation method of oligopeptide cyclic peptide | 杭州彗搏科技有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-12486241-B2 | Cystine diamide analogs for cystinuria | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2025-12-02 | — | — | US | disclosed |
| EP-4608452-A2 | PEPTIDE-ANTISENSE OLIGONUCLEOTIDES AND THEIR USE FOR TREATMENT OF NEURODEGENERATIVE DISORDERS | Eisai R&D Management Co., Ltd. (JP) | 2025-09-03 | — | — | EP | disclosed |
| EP-4577537-A1 | SUBSTITUTED BICYCLES AS HSET INHIBITORS | Merck Patent GmbH (DE) | 2025-07-02 | — | — | EP | disclosed |
| CN-119775349-A | Pyroglutamic acid-tetrapeptide-7 derivative and application thereof | 云南苏理生物医药科技有限公司 | 2025-04-08 | — | — | CN | disclosed |
| CN-119768391-A | Indole phthalocyanine compound, preparation method thereof and application thereof in tumor diagnostic imaging | 江苏亚虹医药科技股份有限公司 | 2025-04-04 | — | — | CN | disclosed |
| CN-119708309-A | Narrow distribution copolymer and preparation method and application thereof | 上海八亿时空先进材料有限公司 | 2025-03-28 | — | — | CN | disclosed |
| US-5578575-A | SEPTIC SHOCK | ITALFARMACO S.P.A. (IT) | 1996-11-26 | — | — | US | disclosed |
| US-5521159-A | Partially modified and retro-inverted tetrapeptides analogues of C-reactive protein fragments | ITALFARMACO S.P.A. (IT) | 1996-05-28 | — | — | US | disclosed |
| EP-0701546-A1 | AROMATIC ACETYLCHOLINESTERASE INHIBITORS | MERRELL PHARMACEUTICALS INC. (US) | 1996-03-20 | — | — | EP | disclosed |
| WO-1994029255-A1 | AROMATIC ACETYLCHOLINESTERASE INHIBITORS | MERRELL PHARMACEUTICALS INC. (US) | 1994-12-22 | — | — | WO | disclosed |
| EP-0627400-A1 | Aromatic acetylcholinesterase inhibitors | MERRELL DOW PHARMACEUTICALS INC. (US) | 1994-12-07 | — | — | EP | disclosed |
| WO-1993021208-A1 | PARTIALLY MODIFIED AND RETRO-INVERTED TETRAPEPTIDES ANALOGUES OF C-REACTIVE PROTEIN FRAGMENTS | ITALFARMACO S.P.A. (IT) | 1993-10-28 | — | — | WO | disclosed |
| US-5196608-A | Chemical intermediates for vitamin A | DUPHAR INTERNATIONAL RESEARCH B.V. (NL) | 1993-03-23 | — | — | US | disclosed |
| EP-0489454-A1 | Use of an allylchloride for preparing an aldehyde | DUPHAR INTERNATIONAL RESEARCH B.V (NL) | 1992-06-10 | — | — | EP | disclosed |
| EP-0456287-A1 | New sulfonyl compound and use of said compound in the process of producing vitamin A or its esters | DUPHAR INTERNATIONAL RESEARCH B.V (NL) | 1991-11-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12486241-B2 | Cystine diamide analogs for cystinuria | CTH, CBS, SLC7A11 | L3MBTL1 1772/4885EPHX1 2058/4885MEN1 446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.